Androgenización en síndrome de ovario poliquístico en paciente que acuden en el Hospital Matilde Hidalgo de Procel
No hay miniatura disponible
Fecha
2018
Autores
Título de la revista
ISSN de la revista
Título del volumen
Editor
Universidad de Guayaquil. Facultad de Ciencias Médicas. Carrera de Obstetricia
Resumen
La androgenizaciòn presenta un exceso en la producción de andrógenos, como consecuencias clínicas que determinarán problemas tanto ginecológicos como dermatológico, sus principales manifestaciones clínicas se relatan como acné, hirsutismo, alopecia, obesidad tipo androide debido a la secreción de colesterol por medio de los esteroides, el objetivo principal fue determinar cuáles son los factores que conllevan a la androgenizaciòn en mujeres en edad reproductiva atendidas en el hospital Matilde Hidalgo de Procel durante el periodo 1 de mayo 2017 – 1 de marzo 2018. La metodología fue de tipo cuantitativo con un diseño no experimental, descriptivo de corte transversal, el universo fue de 212 pacientes. Entre sus principales resultados encontraremos en cuanto a la edad observar que la mayor prevalencia se encuentra en el rango de edad de 31 a 35 años de edad con un 49.35%, seguido del rango de 19 a 30 años, la menor prevalencia la obtuvo el grupo de 12 a 18 años de edad, esto es debido a la gran actividad sexual que tiene este grupo de edad lo cual ayuda a la liberación y tránsito de hormonas, los factores La mayor prevalencia de factores de la androgenizaciòn en este grupo de pacientes es por antecedentes patológicos familiares, en realidad la opción “ningún factor” fue el que más prevalencia tuvo, seguido de síndrome de ovario poliquístico con 25.54% del total de la muestra, la hipertensión es un factor poco predominante para la androgenizaciòn. Y su conclusión principal El principal factor patológico de androgenizaciòn en mujeres que se encuentran en edad reproductiva es el síndrome de ovario poliquístico debido a su cuadro clínico
Androgenization has an excess in the production of androgens, as clinical consequences that will determine both gynecological and dermatological problems, its main clinical manifestations are reported as acne, hirsutism, alopecia, android type obesity due to the secretion of cholesterol by means of steroids, The main objective was to determine which factors lead to androgenization in women of reproductive age treated in the Matilde Hidalgo de Procel hospital during the period May 1, 2017 - March 1, 2018. The methodology was of a quantitative type with a non-invasive design. experimental, descriptive cross section, the universe was of 2120 patients and the sample of 231. Among its main results we will find in terms of age to observe that the highest prevalence is in the age range of 31 to 35 years of age with a 49.35% of the total sample, followed by the range of 19 to 30 years, the lowest prevalence it was obtained by the group of 12 to 18 years of age, this is due to the great sexual activity that this age group has which helps the release and transit of hormones, the factors The higher prevalence of factors of androgenization in this group of patients is due to family medical history, in fact the "no factor" option was the most prevalent, followed by polycystic ovarian syndrome with 25.54% of the total sample, hypertension is a little predominant factor for androgenization. And its main conclusion the main pathological factor of androgenization in women who are of reproductive age is the polycystic ovary syndrome due to its clinical picture
Androgenization has an excess in the production of androgens, as clinical consequences that will determine both gynecological and dermatological problems, its main clinical manifestations are reported as acne, hirsutism, alopecia, android type obesity due to the secretion of cholesterol by means of steroids, The main objective was to determine which factors lead to androgenization in women of reproductive age treated in the Matilde Hidalgo de Procel hospital during the period May 1, 2017 - March 1, 2018. The methodology was of a quantitative type with a non-invasive design. experimental, descriptive cross section, the universe was of 2120 patients and the sample of 231. Among its main results we will find in terms of age to observe that the highest prevalence is in the age range of 31 to 35 years of age with a 49.35% of the total sample, followed by the range of 19 to 30 years, the lowest prevalence it was obtained by the group of 12 to 18 years of age, this is due to the great sexual activity that this age group has which helps the release and transit of hormones, the factors The higher prevalence of factors of androgenization in this group of patients is due to family medical history, in fact the "no factor" option was the most prevalent, followed by polycystic ovarian syndrome with 25.54% of the total sample, hypertension is a little predominant factor for androgenization. And its main conclusion the main pathological factor of androgenization in women who are of reproductive age is the polycystic ovary syndrome due to its clinical picture
Descripción
PDF
Palabras clave
Androgenización, Síndrome de ovario poliquístico, Epidemiología descriptiva, Hospital Materno Infantil Dra. Matilde Hidalgo de Procel, Cantón Guayaquil, Ecuador